THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Globe 100 | Executive roundtable

What the CEOs see

Four biotech leaders on the recession, venture capital, and how their industry can help lead Massachusetts into a recovery

Get Adobe Flash player
By Todd Wallack
Globe Staff / May 19, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The hot, burning core of any recovery in Massachusetts could well be occupied by the state's life sciences companies; for evidence, take the preponderance of biotech firms on this year's Globe 100. (Full article: 1210 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass